Roberto De Ponti
Roberto is Managing Director and General Partner of 3B Future Health Ventures sarl. Prior to this, Roberto was Head of Corporate Business Development at Helsinn. Roberto has held several Senior Director positions in various pharmaceutical companies including Pfizer, Indena, Pharmacia & Upjohn, Nerviano Medical Sciences and Boehringer Mannheim. His extensive background in the pharmaceutical industry includes the development of blockbuster drugs, oversight of R&D and manufacturing as well as licensing and business development. Roberto is on the board of several portfolio companies in Europe and the US. He holds a PharmD degree and is an EU Qualified Person.
Roberto serves as Director on the board of OncoResponse Inc, Domain Therapeutics, Roca Therapeutics, Fore Biotherapeutics, and as Board Observer of iOnctura and Epsilogen.